The purpose of this study was to select healthy Chinese subjects, use the compound reserpine and triamterene capsules provided by Beijing Xinghao Pharmaceutical Co., Ltd. as the test preparation, and conduct human relative bioavailability and bioequivalence tests on the compound reserpine and triamterene tablets (trade name: No. 0, reference preparation) produced by Beijing Shuanghe Pharmaceutical Co., Ltd. on the domestic market in accordance with the relevant BE test regulations, calculate the relative bioavailability of the test preparation, and compare the bioequivalence of the two preparations.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.